Nederlands
English
Nederlands
Asset Management
Beleggingsstrategieën
Client Solutions
Verantwoord beleggen
Merchant Banking
Corporate Finance
Securities
Over Kempen
Contact
Werken bij
News & Knowledge
kempen
Kempen
Corporate Finance
Grontmij October 2015
Grontmij
Ablynx placed 4,908,332 new shares to fund ongoing and future clinical trials
Kempen & Co acted as Joint Bookrunner and generated significant demand resulting in the upsizing of the deal from an initial €30m at launch to a total of €41.7m